Flecainide Info
Clinical Profile of Flecainide
Flecainide belongs to the class Ic anti-arrhythmic agents, a group of medicines that influence the electrical activity of the heart. Its primary therapeutic purpose is to help regulate irregular heart rhythms. The compound is the active substance found in several formulations marketed under the name Flecainide in Singapore.
In Singapore, flecainide is supplied as oral tablets, typically in strengths of 50 mg and 100 mg. Both brand-named and generic versions are authorised by the Health Sciences Authority, allowing patients to receive the same active ingredient regardless of branding. The tablets are designed for swallowing whole with water and are stored at room temperature away from moisture.
Cardiac Conditions Managed with This Agent
- Atrial fibrillation - the drug can assist in maintaining a regular rhythm after cardioversion.
- Atrial flutter - it helps to convert fluttering beats back to a normal sinus rhythm.
- Paroxysmal supraventricular tachycardia (PSVT) - the compound may be used to prevent recurring rapid heartbeats.
- Ventricular premature beats - it can reduce the frequency of isolated extra beats originating from the ventricles.
These applications are generally considered for adults who have been evaluated for the suitability of class Ic therapy.
How Flecainide Influences Heart Rhythm
Flecainide slows the flow of electrical signals through cardiac cells by modestly blocking fast sodium channels. This action stabilises the conduction pathway, making it harder for abnormal impulses to travel and trigger irregular beats. The effect is primarily on the heart’s muscle fibers rather than on the nervous system, providing a focused approach to rhythm control.
Safety Profile and Possible Reactions
Common Reactions
- Light-headedness or dizziness, especially after the first few doses.
- Mild nausea or stomach discomfort that usually improves with continued use.
Rare but Serious Events
- Sudden worsening of arrhythmia, which may present as rapid, irregular heartbeats.
- Severe low blood pressure leading to fainting.
- Allergic responses such as swelling of the face, lips, or throat.
Populations Requiring Caution
- Pregnant individuals should avoid use unless the benefit clearly outweighs potential risk.
- People with known structural heart disease or a history of heart-related conduction problems need thorough assessment before starting therapy.
Interaction Awareness
- Alcohol can amplify dizziness and may affect heart rhythm stability.
- Concurrent use of other anti-arrhythmic drugs, certain antidepressants, and some antibiotics may alter flecainide levels. Detailed interaction tables are available on the specific product information pages.
Practical Points for Patients
- Store tablets in a dry place, below 30 °C, and keep them out of reach of children.
- Treatment length varies: some individuals use flecainide for short-term rhythm conversion, while others may continue long-term maintenance under regular review.
- The exact dosage, timing, and any required monitoring are unique to each formulation and must be read on the medication’s label.
Key Terms Explained
- Anti-arrhythmic - a medication that helps normalize the heart’s electrical rhythm.
- Sodium channel blockade - the process of reducing the movement of sodium ions in heart cells, which slows electrical conduction.
- Cardioversion - a medical procedure that restores a regular heart rhythm, often aided by medication.
- Conduction pathway - the route electrical signals travel through the heart to coordinate beats.
Important Usage Disclosure
This article offers an educational overview of flecainide as an active substance and does not replace professional guidance. Individual products containing this compound may differ in strength, formulation, and recommended use. The provider of this information accepts no liability for clinical decisions based on its content. For precise instructions, dosage details, and personalized advice, refer to the labeling of the specific medication and consult a qualified healthcare professional.
